Adam Kibel is a Genitourinary physician affiliated with Brigham and Women's Hospital. OpenAlex indexes 1,237 publications with 70,166 citations (h-index 105); ClinicalTrials.gov lists 3 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 1% of Urology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
Sponsor: Adam S. Kibel, MD
Overall officialRecruitingNCT06398639 - Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer
Sponsor: Brigham and Women's Hospital
Overall officialPhase 1Enrolling, by, invitationNCT04399876 - Observation or Radical Treatment in Patients With Prostate Cancer
Sponsor: NCIC Clinical Trials Group
Overall officialTerminatedNCT00499174
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
3 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
NIH funding
4 NIH research awards on record, funded 2014–2026 per NIH RePORTER. The latest:
- Polygenic risk stratification combined with mpMRI to identify clinically relevant prostate cancer
Brigham and Women'S Hospital
FY2026$583,246U01CA268810 - NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
Dana-Farber Cancer Inst
FY2025$1,048,779UG1CA233180 - Polygenic risk stratification combined with mpMRI to identify clinically relevant prostate cancer
Brigham and Women'S Hospital
FY2025$707,952U01CA268810
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Dennis Selkoe, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”